Chief Medical Officer Dr. Merit Cudkowicz provides additional information on our mission to fund ALS research to find a cure.
ALS Biomarker Collaboration – Call for Biomarker Discovery ProjectsIn The Media
The ALS Association and ALS Finding a Cure (ALS FAC) are pleased to announce a call for biomarker discovery projects. The call for proposals is open to academia and industry world-wide and is part of a broader initiative, the "ALS Biomarker Collaboration," encouraging the development of new biomarkers in a pre-competitive space. Proposed projects should be completed over 12-18 months.
ALS ACT (Accelerated Therapeutics)
Request for Proposals: Early phase clinical development of novel, high-potential treatments for people with ALSIn The Media
ALS Finding a Cure (ALS FAC), the ALS Association (ALSA) and the Northeast ALS Consortium (NEALS) are pleased to announce a call for phase I/II clinical trial applications for novel, high-potential treatments in Amyotrophic Lateral Sclerosis – ALS ACT. The call for clinical study proposals is intended for academic-industry partnerships, including pharmaceutical, biotherapeutic/biotechnology companies, academic members of NEALS, and ALS scientists throughout the world. Read the full press release below.